is the fda taking tirzepatide off the market No, not GLP-1 medications — but the compounded “copycat” versions may be getting a lot harder to access. This is where patient safety, cost, and access all collide., September 2, 2025: U.S. compounding

Through partnerships in Asia, expertise in logistics, and a relentless focus on secure infrastructure, we have positioned ourselves to deliver exactly what this mandate requires

If side effects persist and remain intolerable despite extended up-titration, a lower maintenance dose may be considered to support adherence and reduce the risk of treatment discontinuation [66]

We are not just a clinic that administers therapies

Young, fresh and innovative - Cool Shot

We partner with you to restore energy, confidence, and metabolic health through compassionate, intelligent care that honors your journey and empowers your progress